159 related articles for article (PubMed ID: 26431531)
1. The Overexpression of FEN1 and RAD54B May Act as Independent Prognostic Factors of Lung Adenocarcinoma.
Hwang JC; Sung WW; Tu HP; Hsieh KC; Yeh CM; Chen CJ; Tai HC; Hsu CT; Shieh GS; Chang JG; Yeh KT; Liu TC
PLoS One; 2015; 10(10):e0139435. PubMed ID: 26431531
[TBL] [Abstract][Full Text] [Related]
2. WDR62 overexpression is associated with a poor prognosis in patients with lung adenocarcinoma.
Shinmura K; Kato H; Kawanishi Y; Igarashi H; Inoue Y; Yoshimura K; Nakamura S; Fujita H; Funai K; Tanahashi M; Niwa H; Ogawa H; Sugimura H
Mol Carcinog; 2017 Aug; 56(8):1984-1991. PubMed ID: 28277612
[TBL] [Abstract][Full Text] [Related]
3. Uncovering synthetic lethal interactions for therapeutic targets and predictive markers in lung adenocarcinoma.
Chang JG; Chen CC; Wu YY; Che TF; Huang YS; Yeh KT; Shieh GS; Yang PC
Oncotarget; 2016 Nov; 7(45):73664-73680. PubMed ID: 27655641
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
[TBL] [Abstract][Full Text] [Related]
5. Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinoma.
Guo T; Zhao S; Li Z; Li F; Li J; Gu C
Cancer Biomark; 2018; 22(2):301-310. PubMed ID: 29630522
[TBL] [Abstract][Full Text] [Related]
6. Specific synthetic lethal killing of RAD54B-deficient human colorectal cancer cells by FEN1 silencing.
McManus KJ; Barrett IJ; Nouhi Y; Hieter P
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3276-81. PubMed ID: 19218431
[TBL] [Abstract][Full Text] [Related]
7. CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients.
Shi R; Zhang C; Wu Y; Wang X; Sun Q; Sun J; Xia W; Dong G; Wang A; Jiang F; Xu L
Oncotarget; 2017 Mar; 8(12):19768-19779. PubMed ID: 28423619
[TBL] [Abstract][Full Text] [Related]
8. Survival prediction for patients with lung adenocarcinoma: A prognostic risk model based on gene mutations.
Geng H; Li S; Guo Y; Yan F; Han Y; Xu M; Cui Y
Cancer Biomark; 2020; 27(4):525-532. PubMed ID: 32083571
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of microRNA-7 and its Roles in the Regulation of Cisplatin Resistance in Lung Adenocarcinoma.
Cheng MW; Shen ZT; Hu GY; Luo LG
Cell Physiol Biochem; 2017; 42(2):660-672. PubMed ID: 28618418
[TBL] [Abstract][Full Text] [Related]
10. High RAD54B expression: an independent predictor of postoperative distant recurrence in colorectal cancer patients.
Nagai Y; Yamamoto Y; Yasuhara T; Hata K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Nozawa H; Kazama S; Yamaguchi H; Ishihara S; Sunami E; Yamanaka T; Miyagawa K; Watanabe T
Oncotarget; 2015 Aug; 6(25):21064-73. PubMed ID: 26046797
[TBL] [Abstract][Full Text] [Related]
11. Programmed death-ligand 1 expression associated with molecular characteristics in surgically resected lung adenocarcinoma.
Song Z; Yu X; Cheng G; Zhang Y
J Transl Med; 2016 Jun; 14(1):188. PubMed ID: 27342566
[TBL] [Abstract][Full Text] [Related]
12. LHX3 is an early stage and radiosensitivity prognostic biomarker in lung adenocarcinoma.
Lin X; Li Y; Wang J; Han F; Lu S; Wang Y; Luo W; Zhang M
Oncol Rep; 2017 Sep; 38(3):1482-1490. PubMed ID: 28731174
[TBL] [Abstract][Full Text] [Related]
13. Increased expression and no mutation of the Flap endonuclease (FEN1) gene in human lung cancer.
Sato M; Girard L; Sekine I; Sunaga N; Ramirez RD; Kamibayashi C; Minna JD
Oncogene; 2003 Oct; 22(46):7243-6. PubMed ID: 14562054
[TBL] [Abstract][Full Text] [Related]
14. High expression of transcriptional factor HoxB9 predicts poor prognosis in patients with lung adenocarcinoma.
Zhan J; Wang P; Niu M; Wang Y; Zhu X; Guo Y; Zhang H
Histopathology; 2015 Jun; 66(7):955-65. PubMed ID: 25324169
[TBL] [Abstract][Full Text] [Related]
15. High PHLPP expression is associated with better prognosis in patients with resected lung adenocarcinoma.
Lv D; Yang H; Wang W; Xie Y; Hu W; Ye M; Chen X
BMC Cancer; 2015 Oct; 15():687. PubMed ID: 26463718
[TBL] [Abstract][Full Text] [Related]
16. An Aggressive Subtype of Stage I Lung Adenocarcinoma with Molecular and Prognostic Characteristics Typical of Advanced Lung Cancers.
Dama E; Melocchi V; Dezi F; Pirroni S; Carletti RM; Brambilla D; Bertalot G; Casiraghi M; Maisonneuve P; Barberis M; Viale G; Vecchi M; Spaggiari L; Bianchi F; Di Fiore PP
Clin Cancer Res; 2017 Jan; 23(1):62-72. PubMed ID: 27358486
[TBL] [Abstract][Full Text] [Related]
17. YY1 suppresses FEN1 over-expression and drug resistance in breast cancer.
Wang J; Zhou L; Li Z; Zhang T; Liu W; Liu Z; Yuan YC; Su F; Xu L; Wang Y; Zhou X; Xu H; Hua Y; Wang YJ; Zheng L; Teng YE; Shen B
BMC Cancer; 2015 Feb; 15():50. PubMed ID: 25885449
[TBL] [Abstract][Full Text] [Related]
18. Elevated nuclear CCND1 expression confers an unfavorable prognosis for early stage lung adenocarcinoma patients.
Xu P; Zhao M; Liu Z; Liu Y; Chen Y; Luo R; Fang W
Int J Clin Exp Pathol; 2015; 8(12):15887-94. PubMed ID: 26884860
[TBL] [Abstract][Full Text] [Related]
19. Gene expression analysis of lung adenocarcinoma and matched adjacent non-tumor lung tissue.
Zhang W; Gong W; Ai H; Tang J; Shen C
Tumori; 2014; 100(3):338-45. PubMed ID: 25076248
[TBL] [Abstract][Full Text] [Related]
20. High risk of benzo[α]pyrene-induced lung cancer in E160D FEN1 mutant mice.
Wu Z; Lin Y; Xu H; Dai H; Zhou M; Tsao S; Zheng L; Shen B
Mutat Res; 2012 Mar; 731(1-2):85-91. PubMed ID: 22155171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]